Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Alberta

$27,000.00

Investigating the role of hepatocyte membrane type 1 matrix metalloproteinase in regulating systemic glucose-lipid metabolism in response to high fat diet-induced metabolic dysfunction

EF 2025-26

Résumé
Currently, about 6 million Canadians are living with type 2 diabetes (T2D), a chronic condition characterized by high fasting blood sugar (hyperglycemia) and reduced sensitivity to insulin, a pancreatic hormone that helps control blood sugar levels. When insulin is first released from the pancreas, it travels to the liver, which acts as a central metabolic hub for processing and storing nutrients, sending signals that fine-tune whole-body sugar metabolism. However, in T2D, the body becomes insulin resistant, resulting in elevated blood sugar. Our research group identified that the liver protein membrane type 1 matrix metalloproteinase (MT1-MMP) may help control blood sugar. Recent advances suggest MT1-MMP acts like molecular scissors, trimming key cell surface proteins for nutrient sensing and signaling. We found that mice lacking functional MT1-MMP in their liver had higher fasting blood sugar but lower insulin and were less responsive to insulin compared to their wild-type littermates. Our preliminary results therefore suggest that 1) liver MT1-MMP reshapes whole-body sugar metabolism and 2) loss of MT1-MMP in the liver decreases the body’s response to insulin. We hypothesize that liver MT1-MMP improves whole body sugar metabolism and is protective against hyperglycemia driven T2D under dietary stress. Using mouse models, I will investigate how 1) the loss of MT1-MMP impacts the sex-specific progression of T2D under a high fat diet and 2) challenge mice with insulin and observe changes to insulin-stimulated sugar uptake and metabolism. Understanding how liver MT1-MMP regulates whole body sugar metabolism under dietary stress will address a critical gap in the early development of T2D, informing new therapeutic strategies that target insulin resistance and diabetes.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
572904
Name
Patel Raj
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the role of hepatocyte membrane type 1 matrix metalloproteinase in regulating systemic glucose-lipid metabolism in response to high fat diet-induced metabolic dysfunction
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Dietary Stress; Glucose Metabolism; Insulin Resistance; Lipid Metabolism; Liver; Matrix Metalloproteinase 14; Metabolic Dysfunction; Obesity; Sex Specific Differences; Type 2 Diabetes
Abstract
Currently, about 6 million Canadians are living with type 2 diabetes (T2D), a chronic condition characterized by high fasting blood sugar (hyperglycemia) and reduced sensitivity to insulin, a pancreatic hormone that helps control blood sugar levels. When insulin is first released from the pancreas, it travels to the liver, which acts as a central metabolic hub for processing and storing nutrients, sending signals that fine-tune whole-body sugar metabolism. However, in T2D, the body becomes insulin resistant, resulting in elevated blood sugar. Our research group identified that the liver protein membrane type 1 matrix metalloproteinase (MT1-MMP) may help control blood sugar. Recent advances suggest MT1-MMP acts like molecular scissors, trimming key cell surface proteins for nutrient sensing and signaling. We found that mice lacking functional MT1-MMP in their liver had higher fasting blood sugar but lower insulin and were less responsive to insulin compared to their wild-type littermates. Our preliminary results therefore suggest that 1) liver MT1-MMP reshapes whole-body sugar metabolism and 2) loss of MT1-MMP in the liver decreases the body’s response to insulin. We hypothesize that liver MT1-MMP improves whole body sugar metabolism and is protective against hyperglycemia driven T2D under dietary stress. Using mouse models, I will investigate how 1) the loss of MT1-MMP impacts the sex-specific progression of T2D under a high fat diet and 2) challenge mice with insulin and observe changes to insulin-stimulated sugar uptake and metabolism. Understanding how liver MT1-MMP regulates whole body sugar metabolism under dietary stress will address a critical gap in the early development of T2D, informing new therapeutic strategies that target insulin resistance and diabetes.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Patel, Raj
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~